ArticlePloS one2017

Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.

Matilde Forcella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.